Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directions
about
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agentsTrabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsThe clone wars - revenge of the metastatic rogue state: the sarcoma paradigm.Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus.Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.
P2860
Camptothecin-based regimens for treatment of ewing sarcoma: past studies and future directions
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Camptothecin-based regimens fo ...... studies and future directions
@ast
Camptothecin-based regimens fo ...... studies and future directions
@en
Camptothecin-based regimens fo ...... studies and future directions
@nl
type
label
Camptothecin-based regimens fo ...... studies and future directions
@ast
Camptothecin-based regimens fo ...... studies and future directions
@en
Camptothecin-based regimens fo ...... studies and future directions
@nl
prefLabel
Camptothecin-based regimens fo ...... studies and future directions
@ast
Camptothecin-based regimens fo ...... studies and future directions
@en
Camptothecin-based regimens fo ...... studies and future directions
@nl
P2860
P356
P1433
P1476
Camptothecin-based regimens fo ...... studies and future directions
@en
P2093
Lars Wagner
P2860
P304
P356
10.1155/2011/957957
P577
2011-04-06T00:00:00Z